These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 21642847)
1. Variables associated with decreasing pain among persons living with human immunodeficiency virus: a longitudinal follow-up study. Koeppe J; Lyda K; Johnson S; Armon C Clin J Pain; 2012 Jan; 28(1):32-8. PubMed ID: 21642847 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with initiation of prolonged analgesic use among patients in the HIV Outpatient Study (HOPS). Koeppe J; Lichtenstein K; Armon C; Chmiel JS; Buchacz K; Wood K; Brooks JT; Clin J Pain; 2011 Oct; 27(8):699-706. PubMed ID: 21540742 [TBL] [Abstract][Full Text] [Related]
3. Ongoing pain despite aggressive opioid pain management among persons with HIV. Koeppe J; Armon C; Lyda K; Nielsen C; Johnson S Clin J Pain; 2010; 26(3):190-8. PubMed ID: 20173432 [TBL] [Abstract][Full Text] [Related]
4. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM; Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [TBL] [Abstract][Full Text] [Related]
5. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275 [TBL] [Abstract][Full Text] [Related]
6. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002. Sanchez TH; Brooks JT; Sullivan PS; Juhasz M; Mintz E; Dworkin MS; Jones JL; Clin Infect Dis; 2005 Dec; 41(11):1621-7. PubMed ID: 16267735 [TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR; Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067 [TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884 [TBL] [Abstract][Full Text] [Related]
10. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment. Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. Chiao EY; Giordano TP; Richardson P; El-Serag HB J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423 [TBL] [Abstract][Full Text] [Related]
13. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Moore RD; Keruly JC Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro. Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762 [TBL] [Abstract][Full Text] [Related]
15. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485 [TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of regression of sciatica and pain in the low back after lumbar macrodiscectomy in human immunodeficiency virus carriers. Eyenga VC; Ngowe NN; Minkande JZ; Ngah JE Spine (Phila Pa 1976); 2008 Jun; 33(13):E411-3. PubMed ID: 18520927 [TBL] [Abstract][Full Text] [Related]
19. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3. Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178 [TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy. Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]